Community-oriented Motivational Interviewing (MI): A novel framework extending MI to address COVID-19 vaccine misinformation in online social media platforms. Academic Article uri icon

Overview

abstract

  • Researchers have linked circulating misinformation in online platforms to low COVID-19 vaccine uptake. Two disparate literatures provide relevant initial guidance to address the problem. Motivational Interviewing (MI) effectively reduces vaccine hesitancy in clinical environments; meanwhile, social scientists note inoculation, rebuttal, and appeals to accuracy are persuasive in digital contexts. A tension is inherent in these approaches. MI in digital forums may induce an 'illusory truth effect,' wherein falsehoods appear more accurate through repetition. Yet, rebutting misinformation directly may elicit backfire or reactance effects, motivating some to amplify their presentation of misinformation. Building on Identity Process Theory, we propose a theoretical framework for conducting MI-based infodemiology interventions among digital communities that conceptualizes the community in toto (rather than one specific person) as the unit of focus. Case examples from interventions on public Facebook posts illustrate three processes unique to such interventions: 1) Navigating tension between addressing commenters and "bystanders"; 2) Activating pro-vaccine bystanders; and 3) Reframing uncertainty or information individuals might find concerning or threatening according to implied collective values. This paper suggests community-oriented MI can maximize persuasive effects on bystanders while minimizing potential reactance from those with committed beliefs, thereby guiding community-oriented public health messaging interventions enacted in digital environments.

authors

  • Scales, David
  • Gorman, Jack M
  • DiCaprio, Peter
  • Hurth, Lindsay
  • Radhnakrishan, Malavika
  • Windham, Savannah
  • Akunne, Azubuike
  • Florman, Julia
  • Leininger, Lindsey
  • Starks, Tyrel J

publication date

  • December 13, 2022

Identity

PubMed Central ID

  • PMC7489495

Digital Object Identifier (DOI)

  • 10.1016/j.chb.2022.107609

PubMed ID

  • 36531901

Additional Document Info

volume

  • 141